Selagine, Inc., a spin-out company from the University of Illinois Chicago (UIC), announced today that the U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IND) clearance ...

Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, ...

Part of the HHS transformation involves decreasing the NIH workforce by about 1,200 “by centralizing procurement, human ... in some form of medical research. “Clinical trials are a key part ...

The biotech firm's leading candidate has just entered phase three clinical ... of Health and Human Services, has also already scheduled phase three trials with 30,000 subjects for the Oxford ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Jason Mast is a general assignment reporter at STAT focused on the science ...

has been awarded a $3 million grant from the National Institutes of Health (NIH) to support Duvax, the first dual-target Alzheimer's vaccine, in its entry into human clinical trials. Nuravax Inc ...

An NHS puberty blocker trial is “not ethical”, according to a Donald Trump-ordered review of children’s gender medicine. The US federal review goes even further than Britain’s Cass Review by raising ...

the Department of Health and Human Services, which oversees the NIH, announced that it will fire 10,000 people. But the federal government’s disregard for clinical trials is one of the most ...

About LIBERATE-1 LIBERATE-1 is a Phase 1, first-in-human study of a miniature, ultra long-acting GLP-1 (exenatide) implant to investigate the safety, tolerability, and full pharmacokinetic profile in ...

The National Institutes of Health (NIH) serves as an important source of funding for clinical trials in children, especially for diseases, such as cancer, that are not as highly prioritized in ...